Cloning And Mutagenesis: Critical Driver Shaping the Surging Demand For Genetically Modified Products To Drive Market Growth Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Cloning And Mutagenesis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market for cloning and mutagenesis has seen a swift expansion. Estimated to rise from $2.98 billion in 2024 to $3.54 billion in 2025, it's expected to experience a compound annual growth rate (CAGR) of 18.7%. Factors contributing to its growth during the historic timeframe include advances in genetic research, a surge in demand within pharmaceutical investigation, the emerging role of genetic engineering in agriculture, its use in biomedical research, and foundational applications within molecular biology.

Cloning And Mutagenesis Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size of cloning and mutagenesis is predicted to witness a swift expansion. By 2029, it is projected to reach $7.13 billion, growing at a compound annual growth rate (CAGR) of 19.2%. The growth during the forecast period is driven by factors such as increased applications in gene therapy, the surge in demand for personalized medicine, progress in functional genomics, breakthroughs in synthetic biology, and usage in agricultural biotechnology. The forecast period will be marked by trends such as targeted gene editing in therapeutics, improved precision and specificity, modifiable molecular tools, broadened applications in agriculture, along with ethical and regulatory considerations.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cloning-and-mutagenesis-global-market-report

What Are the Drivers Transforming the Cloning And Mutagenesis Market?
The surge in the requirement for genetically engineered products is predicted to fuel the expansion of the cloning and mutagenesis industry. Genetic modification refers to the deliberate alteration of an organism's genetic structure to bring forth new attributes through genetic engineering techniques. This applies to any entity, substance, or organism that has undergone genetic modification. Cloning is a scientific procedure that creates identical genetic replicates for diverse living species. It's used to develop insect and plant resistance and in gene therapy within the medical field. Hence, increasing demand for genetically engineered products is fostering cloning and mutagenesis industry growth. For example, in the 2023 annual report released by Bayar AG, a German biopharmaceutical firm, it was shown that the yearly sales of genetically engineered products within crop sciences and pharmaceutical segment had notably risen in comparison to 2021. The data showed yearly sales in the crop sciences division surging to $27,794.38 million in 2022, up from $22,314.79 million in 2021. Ergo, the increasing demand for genetically engineered items is catalyzing the expansion of the cloning and mutagenesis sector.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10541&type=smp

Which Emerging Trends Are Transforming the Cloning And Mutagenesis Market in 2025?
The key players in the cloning and mutagenesis industry are progressing with cutting-edge technologies, such as bacteriophage genome modification technologies, to maintain their stronghold in the market. These technologies offer methodologies and instruments to intentionally modify bacteriophages' genetic material, which are viruses that invade bacteria, and have various applications such as research, therapy, and industry. For instance, iNtRON Biotechnology, a biotech business headquartered in South Korea, introduced their 2nd generation technology for Robot Bacteriophage in October 2022. This technique involves random transposon mutagenesis for bacteriophage genome modification. This innovation, coupled with the previously devised tailored CRISPR/Cas system, facilitates the detection and elimination of non-essential genes in the bacteriophage genome. The goal of the company is to create and manufacture bacteriophages with desired characteristics, enhancing the creation of immunotherapeutic agents and antiviral remedies.

Which Segments in the Cloning And Mutagenesis Market Offer the Most Profit Potential?
The cloning and mutagenesis market covered in this report is segmented -

1) By Product: Cloning Kits, Mutagenesis Kits, Other Product
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End User

Subsegments:
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits
3) By Other Products: Enzymes, Vector Systems, Accessories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10541&type=smp

Which Firms Dominate the Cloning And Mutagenesis Market by Market Share and Revenue in 2025?
Major companies operating in the cloning and mutagenesis market include Thermo Fisher Scientific, Takara Bio Inc., Agilent Technologies Inc., Jena Bioscience GmbH, Transgen Biotech Co, New England Biolabs, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc., Danaher, Genomax Technologies Pte Ltd, GENEWIZ Inc., abm Inc., GenScript, EZBioscience, Codex DNA Inc., Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Integrated DNA Technologies, MedGenome, Sino Biological Inc., BioChain Institute Inc., OriGene Technologies Inc., Creative Biogene, Bioneer Corporation, Synbio Technologies LLC, Lucigen Corporation, Biomatik Corporation, Quanta BioDesign Ltd., Inscripta Inc.

Which Regions Offer the Highest Growth Potential in the Cloning And Mutagenesis Market?
North America was the largest region in the cloning and mutagenesis market in 2024.Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10541

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.